Global Retirement Partners’s Denali Therapeutics DNLI Stock Holding History

Global Retirement Partners’s Portfolio DNLI Stock Details DNLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28.4K	Buy	+1,103	New	+$22.7K	﹤0.01%	2865
2025 Q4	$17	Hold	1	–	–	﹤0.01%	4205
2025 Q3	$15	Sell	1 -2	-67%	-$29	﹤0.01%	3846
2025 Q2	$42	Buy	+3	New	+$42	﹤0.01%	3763
2024 Q4	$61	Hold	3	–	–	﹤0.01%	3573
2024 Q3	$87	Sell	3 -8	-73%	-$198	﹤0.01%	3415
2024 Q2	$255	Hold	11	–	–	﹤0.01%	3397
2024 Q1	$226	Buy	11 +8	+267%	+$150	﹤0.01%	3246
2023 Q4	$55	Hold	3	–	–	﹤0.01%	3289
2023 Q3	$62	Hold	3	–	–	﹤0.01%	3189
2023 Q2	$89	Hold	3	–	–	﹤0.01%	3138
2023 Q1	$78	Hold	3	–	–	﹤0.01%	3135
2022 Q4	$83	Hold	3	–	–	﹤0.01%	2976
2022 Q3	$0	Hold	3	–	–	﹤0.01%	2752
2022 Q2	$0	Hold	3	–	–	﹤0.01%	2722
2022 Q1	$0	Buy	+3	New	+$103	﹤0.01%	2663
2021 Q1	–	Sell	-200	Closed	-$17K	–	1802
2020 Q4	$17K	Hold	200	–	–	﹤0.01%	1085
2020 Q3	$7K	Hold	200	–	–	﹤0.01%	1229
2020 Q2	$5K	Hold	200	–	–	﹤0.01%	1287
2020 Q1	$4K	Hold	200	–	–	﹤0.01%	1269
2019 Q4	$3K	Hold	200	–	–	﹤0.01%	1410
2019 Q3	$3K	Hold	200	–	–	﹤0.01%	1382
2019 Q2	$4K	Hold	200	–	–	﹤0.01%	1321
2019 Q1	$5K	Buy	+200	New	+$4.18K	﹤0.01%	1231

Other funds holding DNLI

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Global Retirement Partners's DNLI Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Denali Therapeutics (DNLI) in Q2 2026: 1,103 shares worth $28.4K. The stake represents ﹤0.01% of the portfolio and ranks #2865 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in DNLI as recently as Q4 2025.

Global Retirement Partners first reported a position in DNLI in Q1 2019 and has held it in 24 quarters since. 294 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

Global Retirement Partners held 1,103 shares of Denali Therapeutics worth $28.4K as of Q2 2026.
Denali Therapeutics was a new Global Retirement Partners position in Q2 2026.
Denali Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #2865 holding.
Global Retirement Partners first reported a position in Denali Therapeutics in Q1 2019 and has held it in 24 quarters since.
294 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.